The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit
later.
We apologize for any inconvenience caused
Clinical Study of Ascending-descending Acupuncture Method Regulation of the Spleen and Stomach for Treatment of Spleen Deficiency-type Diarrhea in Irritable Bowel Syndrome
Author(s): LI Yong-chun
Pages: 25-
27
Year: 2015
Issue:
1
Journal: Shanghai Journal of Acupuncture and Moxibustion
Keyword: Acupuncture therapy; Irritable bowel syndrome; Diarrhea; Serum vasoactive intestinal peptide; 5-hydroxytryptamine; Spleen-qi ascending stomach-qi descending;
Abstract: Objective To investigate the efficacy of ascending-descending acupuncture method regulation of the spleen and stomach in treating spleen deficiency-type diarrhea in irritable bowel syndrome and its effect on serum vasoactive intestinal peptide (VIP) and 5-hydroxytryptamine (5-HT) levels. Methods Sixty irritable bowel syndrome patients with spleen deficiency-type diarrhea were randomly allocated to treatment and control groups, 30 cases each. The treatment group received ascending-descending acupuncture method regulation of the spleen and stomach and the control group, oral administration of pinaverium bromide. The symptom of diarrhea was scored and the vasoactive intestinal peptide and 5-hydroxytryptamine contents of serum were measured in the two groups before and after four weeks of treatment. Results There were statistically significant post-treatment differences in the diarrhea symptom score and serum vasoactive intestinal peptide and 5-hydroxytryptamine contents between the treatment and control groups (P<0.05). There were statistically significant pre-/post-treatment differences in the diarrhea symptom score and serum vasoactive intestinal peptide and 5-hydroxytryptamine contents in the two groups (P<0.05). Conclusion Ascending-descending acupuncture method regulation of the spleen and stomach is an effective way to treat spleen deficiency-type diarrhea in irritable bowel syndrome. It can effectively regulate the vasoactive intestinal peptide and 5-hydroxytryptamine contents of serum in the patients.
Citations
No citation found